CBDV PhytoNano™ Water-Soluble Powder

0 out of 5

Price range: $700.00 through $3,500.00

Engineered for superior performance, our CBDV PhytoNano™ Water-Soluble Powder addresses the challenge of CBDV’s poor water solubility, a BCS Class II compound. Our exclusive PhytoNano™ adsorbant matrix offers high internal porosity (2.1 cm³/g) and expansive specific surface area (400 m²/g) which enhance solubility by stabilizing CBDV in an amorphous form, promoting faster absorption and improved therapeutic outcomes.

The powder’s exceptional flowability (angle of repose: 34° at 1:1 loading) and compressibility produce robust, leak-free tablets or capsules with a hardness of 70 N and minimal friability. Compliant with JPE, USP/NF, and EP pharmacopoeia standards, it guarantees pharmaceutical-grade quality and safety.

Manufactured in USA in an FDA-registered and cGMP-certified facility.

This product is made-to-order to ensure optimal potency and maximum shelf life. Expect an average 12-15 day lead time.

SKU: PPWSPCBDV20 Category:

Description

Our CBDV PhytoNano™ Water-Soluble Powder is versatile and user-friendly, perfect for creating refreshing CBDV-infused drinks or precise nutraceutical formulations. It offers a 3-year shelf life when stored at room temperature in low-humidity conditions. With a neutral pH range of 4.0–8.0 and low moisture content (2.6% loss on drying), it maintains stability across various applications. Elevate your wellness journey with our CBDV PhytoNano™ Water-Soluble Powder, available for purchase now and designed to redefine CBDV delivery with unparalleled quality and performance.

Cannabidivarin (CBDV) Hemp Extract and Its Potential for Product Innovation as a Nanoemulsion Water-Soluble Powder

CBDV nanoemulsion water-soluble powder represents a frontier in cannabinoid-based product innovation. With its promising neurological benefits, rapid onset delivery, and versatile formulation options, CBDV stands to become a key ingredient in the next wave of hemp-derived nutraceuticals and functional wellness products. As regulatory frameworks evolve and clinical research continues to support its efficacy and safety, CBDV nanoformulations will likely play a pivotal role in specialized health categories with high unmet demand.

Introduction to Cannabidivarin (CBDV)

Cannabidivarin (CBDV) is a non-intoxicating cannabinoid naturally found in low concentrations in hemp and cannabis plants, particularly in landrace indica strains and fiber-type industrial hemp. Structurally similar to cannabidiol (CBD), CBDV is a propyl analog (with a shorter side chain) and is drawing increasing interest for its unique pharmacological properties—especially in the areas of neurological and neurodevelopmental disorders.

While CBD dominates the wellness and nutraceutical markets, CBDV remains a relatively untapped compound with significant potential for innovative product development. Its distinctive effects and safety profile make it an ideal candidate for specialized applications in both dietary supplements and functional foods.

Emerging Health Applications of CBDV

CBDV is being actively studied for a range of therapeutic benefits, particularly:

Neurological and Anticonvulsant Properties:

CBDV has shown promise in reducing the severity and frequency of seizures. Research conducted on rodent models indicates that CBDV may modulate neurochemical pathways related to epilepsy. It has been granted orphan drug status by the FDA for treatment of Rett syndrome and Fragile X syndrome.

Autism Spectrum Disorders (ASD):

Preliminary studies suggest that CBDV may help manage behaviors associated with ASD, such as irritability, hyperactivity, and repetitive behaviors.

Anti-inflammatory and Analgesic Effects:

Like other cannabinoids, CBDV may exert anti-inflammatory effects by interacting with the endocannabinoid system (ECS), making it potentially useful for chronic pain and inflammation.

Muscle Function and Recovery:

Early investigations suggest it may support muscle coordination and recovery, opening opportunities for sports nutrition applications.

Why Nanoemulsion Technology for CBDV?

CBDV, like other cannabinoids, is hydrophobic—meaning it does not dissolve well in water. This poses challenges for formulation in aqueous beverages and limits its bioavailability when taken orally. Nanoemulsion technology addresses these issues by transforming oil-based cannabinoids into a water-dispersible format using nanoscale emulsification.

Key Benefits of CBDV Nanoemulsion Water-Soluble Powder:

Enhanced Bioavailability:

Nanoemulsions increase the surface area of CBDV molecules, improving absorption rates and onset time compared to oil-based formats.

Rapid Onset:

Water-soluble CBDV formulations typically deliver faster effects, making them ideal for acute-use products like stress relief, focus, or workout recovery.

Versatile Applications:

  • Functional beverages
  • Instant powders (drink mixes, sachets)
  • Gummies and chewables
  • Capsules and tablets
  • Nutraceutical shots and effervescent tablets

Dose Precision:

Water-soluble powders offer consistent dosing and ease of measurement, critical for clinical trials or therapeutic use cases.

Stability and Shelf Life:

Well-formulated nanoemulsions show excellent stability against heat, pH, and light, making them suitable for a wide range of product environments.

Innovative Product Development Opportunities

The uniqueness of CBDV lends itself to premium and niche markets seeking differentiation from the crowded CBD category. Below are innovation pathways for CBDV nanoemulsion powders:

Product Type 

Functional Drink Powders 

Fast-Acting Gummies

Sports Recovery Tablets 

Pediatric-Friendly Oral Powders

Cognitive Health Supplements

Innovation Concept

CBDV + L-Theanine + Magnesium for neurocalming and focus

CBDV nano + Rhodiola + B6 for mood stabilization and energy

CBDV + Electrolytes + Curcumin for inflammation and muscle repair

Sugar-free flavored powder for potential use in ASD or Fragile X protocols (clinical)

CBDV + Lion’s Mane + Choline for neuroplasticity and cognitive enhancement

Regulatory and Market Outlook

Regulatory Pathways:

While CBD is widely sold under dietary supplement guidance in the U.S., CBDV currently resides in a regulatory gray zone. However, its non-intoxicating nature and growing body of safety data may support future inclusion in the FDA’s framework for dietary supplements and functional foods.

Patent Landscape:

CBDV is a target of growing IP filings, particularly in Europe and the U.S., related to neurological disorders and nanoformulations. Companies developing proprietary delivery systems can carve a competitive moat via encapsulation or powderization techniques.

Market Differentiation:

CBDV offers a compelling angle for brands seeking differentiation from the oversaturated CBD market. Its niche therapeutic profile appeals to health-conscious consumers, biohackers, and parents of children with developmental disorders.

Custom Formulations Available

Our exclusive PhytoNano™ Adsorption Technology can provide custom formulation concentrations of up to 40% cannabidivarin (400 milligrams/gram) with bespoke excipients or active ingredients.

Request A Custom Formula Quote:

Additional information

WeightN/A
DimensionsN/A